Non-alcoholic fatty liver disease: An early mediator predicting metabolic syndrome in obese children?

World Journal of Gastroenterology

Volumn 17, Issue 6, 2011, Pages 735-742

  Fu, Jun Fen ^a   Shi, Hong Bo ^a,b   Liu, Li Rui ^a   Jiang, Ping ^a,c   Liang, Li ^a   Wang, Chun Lin ^a   Liu, Xi Yong ^d  

^a CHILDREN S HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b The People s Hospital of Yinzhou   (China)

^c HANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^d CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Childhood obesity; Liver B ultrasonography; Metabolic syndrome; Non alcoholic fatty liver disease

Indexed keywords

AMINOTRANSFERASE; GLUCOSE;

ADOLESCENT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; BODY MASS; CHILD; CONTROLLED STUDY; DIET RESTRICTION; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; HYPERTENSION; INCIDENCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; PREDICTION; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD; ULTRASOUND; WAIST CIRCUMFERENCE;

EID: 79955935615     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i6.735     Document Type: Article

References (30)

1. Manco M, Marcellini M, Devito R, Comparcola D, Sartorelli MR, Nobili V. Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis. Int J Obes (Lond) 2008; 32: 381-387
2. Calcaterra V, Klersy C, Muratori T, Telli S, Caramagna C, Scaglia F, Cisternino M, Larizza D. Prevalence of metabolic syndrome (MS) in children and adolescents with varying degrees of obesity. Clin Endocrinol (Oxf) 2008; 68: 868-872
3. Schwimmer JB, McGreal N, Deutsch R, Finegold MJ, Lavine JE. Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. Pediatrics 2005; 115: e561-e565
4. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006; 43: S99-S112
5. Wieckowska A, Feldstein AE. Nonalcoholic fatty liver disease in the pediatric population: a review. Curr Opin Pediatr 2005; 17: 636-641
6. Marion AW, Baker AJ, Dhawan A. Fatty liver disease in children. Arch Dis Child 2004; 89: 648-652
7. Angelico F, Del Ben M, Conti R, Francioso S, Feole K, Fiorello S, Cavallo MG, Zalunardo B, Lirussi F, Alessandri C, Violi F. Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease. J Clin Endocrinol Metab 2005; 90: 1578-1582
8. Schwimmer JB, Deutsch R, Rauch JB, Behling C, Newbury R, Lavine JE. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr 2003; 143: 500-505
9. Hamaguchi M, Kojima T, Takeda N, Nagata C, Takeda J, Sarui H, Kawahito Y, Yoshida N, Suetsugu A, Kato T, Okuda J, Ida K, Yoshikawa T. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol 2007; 13: 1579-1584
10. Santoliquido A, Di Campli C, Miele L, Gabrieli ML, Forgione A, Zocco MA, Lupascu A, Di Giorgio A, Flore R, Pola P, Gasbarrini G, Gasbarrini A, Tondi P, Grieco A. Hepatic steatosis and vascular disease. Eur Rev Med Pharmacol Sci 2005; 9: 269-271
11. Adams LA, Waters OR, Knuiman MW, Elliott RR, Olynyk JK. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study. Am J Gastroenterol 2009; 104: 861-867
12. Saito T, Misawa K, Kawata S. 1. Fatty liver and non-alcoholic steatohepatitis. Intern Med 2007; 46: 101-103
13. Marchesini G, Babini M. Nonalcoholic fatty liver disease and the metabolic syndrome. Minerva Cardioangiol 2006; 54: 229-239
14. Fan JG. Impact of non-alcoholic fatty liver disease on accelerated metabolic complications. J Dig Dis 2008; 9: 63-67
15. Hu YM, Jiang ZF. Practical Pediatric Textbook of Fu-Tang Zhu. 7th ed. Beijing: People's Hygiene Publishing, 27-30, 553, 1414, 2687
16. Chinese Obese Problem Work Team. BMI classification standard of Chinese school-age child and adolescents for overweight and obesity. Zhonghua Liuxingbingxue Zazhi 2004; 25: 97-102
17. Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association. Guidelines for diagnosis and treatment of nonalcoholic fatty liver disease. Zhonghua Ganzangbing Zazhi 2006; 14: 161-163
18. Fu JF, Liang L, Zou CC, Hong F, Wang CL, Wang XM, Zhao ZY. Prevalence of the metabolic syndrome in Zhejiang Chinese obese children and adolescents and the effect of metformin combined with lifestyle intervention. Int J Obes (Lond) 2007; 31: 15-22
19. Osawa H, Mori Y. Sonographic diagnosis of fatty liver using a histogram technique that compares liver and renal cortical echo amplitudes. J Clin Ultrasound 1996; 24: 25-29
20. Yajima Y, Ohta K, Narui T, Abe R, Suzuki H, Ohtsuki M. Ultrasonographical diagnosis of fatty liver: significance of the liver-kidney contrast. Tohoku J Exp Med 1983; 139: 43-50
21. Gallagher EJ, LeRoith D, Karnieli E. The metabolic syndrome--from insulin resistance to obesity and diabetes. Endocrinol Metab Clin North Am 2008; 37: 559-579, vii
22. Bitsori M, Kafatos A. Dysmetabolic syndrome in childhood and adolescence. Acta Paediatr 2005; 94: 995-1005
23. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics 2006; 118: 1388-1393
24. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50: 1844-1850
25. Lonardo A, Lombardini S, Scaglioni F, Carulli L, Ricchi M, Ganazzi D, Adinolfi LE, Ruggiero G, Carulli N, Loria P. Hepatic steatosis and insulin resistance: does etiology make a difference? J Hepatol 2006; 44: 190-196
26. Choudhury J, Sanyal AJ. Insulin resistance in NASH. Front Biosci 2005; 10: 1520-1533
27. Graif M, Yanuka M, Baraz M, Blank A, Moshkovitz M, Kessler A, Gilat T, Weiss J, Walach E, Amazeen P, Irving CS. Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease. Invest Radiol 2000; 35: 319-324
28. Wieckowska A, McCullough AJ, Feldstein AE. Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future. Hepatology 2007; 46: 582-589
29. Targher G. Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens. Diabet Med 2007; 24: 1-6
30. Lidofsky SD. Nonalcoholic fatty liver disease: diagnosis and relation to metabolic syndrome and approach to treatment. Curr Diab Rep 2008; 8: 25-30